nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—PTGS1—Etoposide—urinary bladder cancer	0.0717	0.177	CbGbCtD
Terbinafine—CYP3A4—Thiotepa—urinary bladder cancer	0.0619	0.153	CbGbCtD
Terbinafine—CYP2C8—Fluorouracil—urinary bladder cancer	0.0496	0.122	CbGbCtD
Terbinafine—CYP2C8—Etoposide—urinary bladder cancer	0.0414	0.102	CbGbCtD
Terbinafine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0384	0.0947	CbGbCtD
Terbinafine—CYP2C9—Fluorouracil—urinary bladder cancer	0.0346	0.0854	CbGbCtD
Terbinafine—CYP1A2—Etoposide—urinary bladder cancer	0.032	0.0791	CbGbCtD
Terbinafine—CYP2C9—Cisplatin—urinary bladder cancer	0.0294	0.0725	CbGbCtD
Terbinafine—CYP2D6—Doxorubicin—urinary bladder cancer	0.018	0.0444	CbGbCtD
Terbinafine—CYP3A4—Etoposide—urinary bladder cancer	0.0168	0.0414	CbGbCtD
Terbinafine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0114	0.0283	CbGbCtD
Terbinafine—SQLE—prostate gland—urinary bladder cancer	0.00761	0.0976	CbGeAlD
Terbinafine—CYP2C19—urine—urinary bladder cancer	0.00741	0.095	CbGeAlD
Terbinafine—CYP1A2—urine—urinary bladder cancer	0.00605	0.0776	CbGeAlD
Terbinafine—CYP2C9—urine—urinary bladder cancer	0.00574	0.0736	CbGeAlD
Terbinafine—CYP3A4—urine—urinary bladder cancer	0.00438	0.0562	CbGeAlD
Terbinafine—CYP2D6—urine—urinary bladder cancer	0.00431	0.0553	CbGeAlD
Terbinafine—SQLE—female reproductive system—urinary bladder cancer	0.00416	0.0533	CbGeAlD
Terbinafine—SQLE—vagina—urinary bladder cancer	0.00376	0.0482	CbGeAlD
Terbinafine—CYP19A1—prostate gland—urinary bladder cancer	0.00324	0.0416	CbGeAlD
Terbinafine—CYP11A1—female reproductive system—urinary bladder cancer	0.00272	0.0349	CbGeAlD
Terbinafine—SQLE—lymph node—urinary bladder cancer	0.00243	0.0312	CbGeAlD
Terbinafine—PTGS1—prostate gland—urinary bladder cancer	0.00188	0.0241	CbGeAlD
Terbinafine—CYP19A1—female reproductive system—urinary bladder cancer	0.00177	0.0227	CbGeAlD
Terbinafine—CYP11A1—lymph node—urinary bladder cancer	0.00159	0.0204	CbGeAlD
Terbinafine—PTGS1—seminal vesicle—urinary bladder cancer	0.00159	0.0204	CbGeAlD
Terbinafine—CYP2C8—renal system—urinary bladder cancer	0.00158	0.0203	CbGeAlD
Terbinafine—CYP1A2—renal system—urinary bladder cancer	0.00148	0.019	CbGeAlD
Terbinafine—PTGS1—epithelium—urinary bladder cancer	0.00138	0.0177	CbGeAlD
Terbinafine—PTGS1—smooth muscle tissue—urinary bladder cancer	0.00133	0.0171	CbGeAlD
Terbinafine—CYP2C19—vagina—urinary bladder cancer	0.00131	0.0168	CbGeAlD
Terbinafine—PTGS1—renal system—urinary bladder cancer	0.00128	0.0164	CbGeAlD
Terbinafine—CYP2C8—female reproductive system—urinary bladder cancer	0.00127	0.0162	CbGeAlD
Terbinafine—CYP2C8—vagina—urinary bladder cancer	0.00115	0.0147	CbGeAlD
Terbinafine—CYP2C9—female reproductive system—urinary bladder cancer	0.00113	0.0144	CbGeAlD
Terbinafine—CYP3A4—renal system—urinary bladder cancer	0.00107	0.0137	CbGeAlD
Terbinafine—CYP2D6—renal system—urinary bladder cancer	0.00105	0.0135	CbGeAlD
Terbinafine—CYP19A1—lymph node—urinary bladder cancer	0.00104	0.0133	CbGeAlD
Terbinafine—PTGS1—female reproductive system—urinary bladder cancer	0.00103	0.0132	CbGeAlD
Terbinafine—PTGS1—vagina—urinary bladder cancer	0.000929	0.0119	CbGeAlD
Terbinafine—CYP3A4—female reproductive system—urinary bladder cancer	0.000858	0.011	CbGeAlD
Terbinafine—CYP2D6—female reproductive system—urinary bladder cancer	0.000844	0.0108	CbGeAlD
Terbinafine—PTGS1—lymph node—urinary bladder cancer	0.000601	0.00771	CbGeAlD
Terbinafine—Pancytopenia—Epirubicin—urinary bladder cancer	0.000343	0.0011	CcSEcCtD
Terbinafine—Gastritis—Doxorubicin—urinary bladder cancer	0.000342	0.0011	CcSEcCtD
Terbinafine—Pain—Cisplatin—urinary bladder cancer	0.000342	0.0011	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000341	0.0011	CcSEcCtD
Terbinafine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000339	0.00109	CcSEcCtD
Terbinafine—Neutropenia—Epirubicin—urinary bladder cancer	0.000338	0.00109	CcSEcCtD
Terbinafine—Dizziness—Thiotepa—urinary bladder cancer	0.000338	0.00108	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000336	0.00108	CcSEcCtD
Terbinafine—Urticaria—Fluorouracil—urinary bladder cancer	0.000335	0.00108	CcSEcCtD
Terbinafine—Influenza—Doxorubicin—urinary bladder cancer	0.000334	0.00107	CcSEcCtD
Terbinafine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000334	0.00107	CcSEcCtD
Terbinafine—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000331	0.00106	CcSEcCtD
Terbinafine—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.00033	0.00106	CcSEcCtD
Terbinafine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00033	0.00106	CcSEcCtD
Terbinafine—Paraesthesia—Etoposide—urinary bladder cancer	0.000329	0.00106	CcSEcCtD
Terbinafine—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000328	0.00105	CcSEcCtD
Terbinafine—Weight decreased—Epirubicin—urinary bladder cancer	0.000327	0.00105	CcSEcCtD
Terbinafine—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000326	0.00105	CcSEcCtD
Terbinafine—Vomiting—Thiotepa—urinary bladder cancer	0.000325	0.00104	CcSEcCtD
Terbinafine—Infestation NOS—Epirubicin—urinary bladder cancer	0.000322	0.00104	CcSEcCtD
Terbinafine—Infestation—Epirubicin—urinary bladder cancer	0.000322	0.00104	CcSEcCtD
Terbinafine—Rash—Thiotepa—urinary bladder cancer	0.000322	0.00103	CcSEcCtD
Terbinafine—Dermatitis—Thiotepa—urinary bladder cancer	0.000322	0.00103	CcSEcCtD
Terbinafine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000321	0.00103	CcSEcCtD
Terbinafine—Headache—Thiotepa—urinary bladder cancer	0.00032	0.00103	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000319	0.00103	CcSEcCtD
Terbinafine—Decreased appetite—Etoposide—urinary bladder cancer	0.000319	0.00102	CcSEcCtD
Terbinafine—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000318	0.00102	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000317	0.00102	CcSEcCtD
Terbinafine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000316	0.00102	CcSEcCtD
Terbinafine—Fatigue—Etoposide—urinary bladder cancer	0.000316	0.00102	CcSEcCtD
Terbinafine—Jaundice—Epirubicin—urinary bladder cancer	0.000314	0.00101	CcSEcCtD
Terbinafine—Pain—Etoposide—urinary bladder cancer	0.000314	0.00101	CcSEcCtD
Terbinafine—Neutropenia—Doxorubicin—urinary bladder cancer	0.000313	0.001	CcSEcCtD
Terbinafine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000311	0.001	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000311	0.000999	CcSEcCtD
Terbinafine—Hepatitis—Methotrexate—urinary bladder cancer	0.000309	0.000993	CcSEcCtD
Terbinafine—Asthenia—Gemcitabine—urinary bladder cancer	0.000308	0.00099	CcSEcCtD
Terbinafine—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000305	0.000981	CcSEcCtD
Terbinafine—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000305	0.000979	CcSEcCtD
Terbinafine—Pruritus—Gemcitabine—urinary bladder cancer	0.000304	0.000976	CcSEcCtD
Terbinafine—Nausea—Thiotepa—urinary bladder cancer	0.000303	0.000974	CcSEcCtD
Terbinafine—Weight decreased—Doxorubicin—urinary bladder cancer	0.000303	0.000972	CcSEcCtD
Terbinafine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000302	0.000971	CcSEcCtD
Terbinafine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000301	0.000966	CcSEcCtD
Terbinafine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.0003	0.000964	CcSEcCtD
Terbinafine—Pruritus—Fluorouracil—urinary bladder cancer	0.000299	0.00096	CcSEcCtD
Terbinafine—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000298	0.000958	CcSEcCtD
Terbinafine—Infestation—Doxorubicin—urinary bladder cancer	0.000298	0.000958	CcSEcCtD
Terbinafine—Visual impairment—Methotrexate—urinary bladder cancer	0.000298	0.000957	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000296	0.00095	CcSEcCtD
Terbinafine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000295	0.000948	CcSEcCtD
Terbinafine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000294	0.000944	CcSEcCtD
Terbinafine—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000292	0.000939	CcSEcCtD
Terbinafine—Urticaria—Etoposide—urinary bladder cancer	0.000291	0.000936	CcSEcCtD
Terbinafine—Jaundice—Doxorubicin—urinary bladder cancer	0.000291	0.000934	CcSEcCtD
Terbinafine—Abdominal pain—Etoposide—urinary bladder cancer	0.00029	0.000931	CcSEcCtD
Terbinafine—Body temperature increased—Etoposide—urinary bladder cancer	0.00029	0.000931	CcSEcCtD
Terbinafine—Hepatitis—Epirubicin—urinary bladder cancer	0.000289	0.00093	CcSEcCtD
Terbinafine—Eye disorder—Methotrexate—urinary bladder cancer	0.000289	0.000928	CcSEcCtD
Terbinafine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000289	0.000928	CcSEcCtD
Terbinafine—Tinnitus—Methotrexate—urinary bladder cancer	0.000288	0.000926	CcSEcCtD
Terbinafine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000288	0.000925	CcSEcCtD
Terbinafine—Asthenia—Cisplatin—urinary bladder cancer	0.000287	0.000923	CcSEcCtD
Terbinafine—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000284	0.000914	CcSEcCtD
Terbinafine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000282	0.000906	CcSEcCtD
Terbinafine—Angiopathy—Methotrexate—urinary bladder cancer	0.00028	0.000901	CcSEcCtD
Terbinafine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000279	0.000897	CcSEcCtD
Terbinafine—Dizziness—Fluorouracil—urinary bladder cancer	0.000279	0.000897	CcSEcCtD
Terbinafine—Visual impairment—Epirubicin—urinary bladder cancer	0.000279	0.000896	CcSEcCtD
Terbinafine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000278	0.000894	CcSEcCtD
Terbinafine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000274	0.00088	CcSEcCtD
Terbinafine—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000274	0.000879	CcSEcCtD
Terbinafine—Alopecia—Methotrexate—urinary bladder cancer	0.000273	0.000878	CcSEcCtD
Terbinafine—Vomiting—Gemcitabine—urinary bladder cancer	0.000273	0.000877	CcSEcCtD
Terbinafine—Mental disorder—Methotrexate—urinary bladder cancer	0.000271	0.00087	CcSEcCtD
Terbinafine—Rash—Gemcitabine—urinary bladder cancer	0.000271	0.00087	CcSEcCtD
Terbinafine—Dermatitis—Gemcitabine—urinary bladder cancer	0.00027	0.000869	CcSEcCtD
Terbinafine—Eye disorder—Epirubicin—urinary bladder cancer	0.00027	0.000869	CcSEcCtD
Terbinafine—Hypersensitivity—Etoposide—urinary bladder cancer	0.00027	0.000868	CcSEcCtD
Terbinafine—Tinnitus—Epirubicin—urinary bladder cancer	0.00027	0.000867	CcSEcCtD
Terbinafine—Erythema—Methotrexate—urinary bladder cancer	0.000269	0.000865	CcSEcCtD
Terbinafine—Headache—Gemcitabine—urinary bladder cancer	0.000269	0.000864	CcSEcCtD
Terbinafine—Vomiting—Fluorouracil—urinary bladder cancer	0.000268	0.000863	CcSEcCtD
Terbinafine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000268	0.00086	CcSEcCtD
Terbinafine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000266	0.000856	CcSEcCtD
Terbinafine—Rash—Fluorouracil—urinary bladder cancer	0.000266	0.000855	CcSEcCtD
Terbinafine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000266	0.000855	CcSEcCtD
Terbinafine—Headache—Fluorouracil—urinary bladder cancer	0.000264	0.00085	CcSEcCtD
Terbinafine—Dysgeusia—Methotrexate—urinary bladder cancer	0.000264	0.000847	CcSEcCtD
Terbinafine—Asthenia—Etoposide—urinary bladder cancer	0.000263	0.000845	CcSEcCtD
Terbinafine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000263	0.000845	CcSEcCtD
Terbinafine—Angiopathy—Epirubicin—urinary bladder cancer	0.000262	0.000843	CcSEcCtD
Terbinafine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000261	0.00084	CcSEcCtD
Terbinafine—Pruritus—Etoposide—urinary bladder cancer	0.000259	0.000834	CcSEcCtD
Terbinafine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000258	0.000829	CcSEcCtD
Terbinafine—Alopecia—Epirubicin—urinary bladder cancer	0.000256	0.000822	CcSEcCtD
Terbinafine—Nausea—Gemcitabine—urinary bladder cancer	0.000255	0.00082	CcSEcCtD
Terbinafine—Vomiting—Cisplatin—urinary bladder cancer	0.000254	0.000818	CcSEcCtD
Terbinafine—Vision blurred—Methotrexate—urinary bladder cancer	0.000254	0.000815	CcSEcCtD
Terbinafine—Mental disorder—Epirubicin—urinary bladder cancer	0.000253	0.000814	CcSEcCtD
Terbinafine—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000253	0.000813	CcSEcCtD
Terbinafine—Rash—Cisplatin—urinary bladder cancer	0.000252	0.000811	CcSEcCtD
Terbinafine—Dermatitis—Cisplatin—urinary bladder cancer	0.000252	0.00081	CcSEcCtD
Terbinafine—Erythema—Epirubicin—urinary bladder cancer	0.000252	0.000809	CcSEcCtD
Terbinafine—Diarrhoea—Etoposide—urinary bladder cancer	0.000251	0.000806	CcSEcCtD
Terbinafine—Nausea—Fluorouracil—urinary bladder cancer	0.000251	0.000806	CcSEcCtD
Terbinafine—Eye disorder—Doxorubicin—urinary bladder cancer	0.00025	0.000804	CcSEcCtD
Terbinafine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.00025	0.000802	CcSEcCtD
Terbinafine—Tinnitus—Doxorubicin—urinary bladder cancer	0.00025	0.000802	CcSEcCtD
Terbinafine—Anaemia—Methotrexate—urinary bladder cancer	0.000249	0.000799	CcSEcCtD
Terbinafine—Flatulence—Epirubicin—urinary bladder cancer	0.000248	0.000797	CcSEcCtD
Terbinafine—Dysgeusia—Epirubicin—urinary bladder cancer	0.000247	0.000793	CcSEcCtD
Terbinafine—Angiopathy—Doxorubicin—urinary bladder cancer	0.000243	0.00078	CcSEcCtD
Terbinafine—Malaise—Methotrexate—urinary bladder cancer	0.000243	0.00078	CcSEcCtD
Terbinafine—Dizziness—Etoposide—urinary bladder cancer	0.000242	0.000779	CcSEcCtD
Terbinafine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000242	0.000778	CcSEcCtD
Terbinafine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000242	0.000777	CcSEcCtD
Terbinafine—Vertigo—Methotrexate—urinary bladder cancer	0.000242	0.000777	CcSEcCtD
Terbinafine—Nausea—Cisplatin—urinary bladder cancer	0.000238	0.000764	CcSEcCtD
Terbinafine—Vision blurred—Epirubicin—urinary bladder cancer	0.000237	0.000763	CcSEcCtD
Terbinafine—Alopecia—Doxorubicin—urinary bladder cancer	0.000237	0.00076	CcSEcCtD
Terbinafine—Cough—Methotrexate—urinary bladder cancer	0.000235	0.000755	CcSEcCtD
Terbinafine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000234	0.000754	CcSEcCtD
Terbinafine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000234	0.000751	CcSEcCtD
Terbinafine—Vomiting—Etoposide—urinary bladder cancer	0.000233	0.000749	CcSEcCtD
Terbinafine—Erythema—Doxorubicin—urinary bladder cancer	0.000233	0.000749	CcSEcCtD
Terbinafine—Anaemia—Epirubicin—urinary bladder cancer	0.000233	0.000748	CcSEcCtD
Terbinafine—Rash—Etoposide—urinary bladder cancer	0.000231	0.000743	CcSEcCtD
Terbinafine—Dermatitis—Etoposide—urinary bladder cancer	0.000231	0.000742	CcSEcCtD
Terbinafine—Headache—Etoposide—urinary bladder cancer	0.00023	0.000738	CcSEcCtD
Terbinafine—Flatulence—Doxorubicin—urinary bladder cancer	0.00023	0.000738	CcSEcCtD
Terbinafine—Arthralgia—Methotrexate—urinary bladder cancer	0.000229	0.000736	CcSEcCtD
Terbinafine—Chest pain—Methotrexate—urinary bladder cancer	0.000229	0.000736	CcSEcCtD
Terbinafine—Myalgia—Methotrexate—urinary bladder cancer	0.000229	0.000736	CcSEcCtD
Terbinafine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000228	0.000733	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000228	0.000731	CcSEcCtD
Terbinafine—Malaise—Epirubicin—urinary bladder cancer	0.000227	0.00073	CcSEcCtD
Terbinafine—Discomfort—Methotrexate—urinary bladder cancer	0.000226	0.000727	CcSEcCtD
Terbinafine—Vertigo—Epirubicin—urinary bladder cancer	0.000226	0.000727	CcSEcCtD
Terbinafine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000224	0.00072	CcSEcCtD
Terbinafine—Confusional state—Methotrexate—urinary bladder cancer	0.000221	0.000712	CcSEcCtD
Terbinafine—Cough—Epirubicin—urinary bladder cancer	0.00022	0.000706	CcSEcCtD
Terbinafine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00022	0.000706	CcSEcCtD
Terbinafine—Vision blurred—Doxorubicin—urinary bladder cancer	0.00022	0.000706	CcSEcCtD
Terbinafine—Infection—Methotrexate—urinary bladder cancer	0.000218	0.000701	CcSEcCtD
Terbinafine—Nausea—Etoposide—urinary bladder cancer	0.000218	0.0007	CcSEcCtD
Terbinafine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000216	0.000695	CcSEcCtD
Terbinafine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000215	0.000692	CcSEcCtD
Terbinafine—Anaemia—Doxorubicin—urinary bladder cancer	0.000215	0.000692	CcSEcCtD
Terbinafine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000215	0.000691	CcSEcCtD
Terbinafine—Chest pain—Epirubicin—urinary bladder cancer	0.000214	0.000689	CcSEcCtD
Terbinafine—Myalgia—Epirubicin—urinary bladder cancer	0.000214	0.000689	CcSEcCtD
Terbinafine—Arthralgia—Epirubicin—urinary bladder cancer	0.000214	0.000689	CcSEcCtD
Terbinafine—Anxiety—Epirubicin—urinary bladder cancer	0.000214	0.000687	CcSEcCtD
Terbinafine—Skin disorder—Methotrexate—urinary bladder cancer	0.000213	0.000686	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000213	0.000684	CcSEcCtD
Terbinafine—Discomfort—Epirubicin—urinary bladder cancer	0.000212	0.000681	CcSEcCtD
Terbinafine—Malaise—Doxorubicin—urinary bladder cancer	0.00021	0.000675	CcSEcCtD
Terbinafine—Dry mouth—Epirubicin—urinary bladder cancer	0.00021	0.000674	CcSEcCtD
Terbinafine—Vertigo—Doxorubicin—urinary bladder cancer	0.000209	0.000673	CcSEcCtD
Terbinafine—Anorexia—Methotrexate—urinary bladder cancer	0.000209	0.000673	CcSEcCtD
Terbinafine—Confusional state—Epirubicin—urinary bladder cancer	0.000207	0.000666	CcSEcCtD
Terbinafine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000206	0.000661	CcSEcCtD
Terbinafine—Infection—Epirubicin—urinary bladder cancer	0.000204	0.000656	CcSEcCtD
Terbinafine—Cough—Doxorubicin—urinary bladder cancer	0.000203	0.000653	CcSEcCtD
Terbinafine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000202	0.000648	CcSEcCtD
Terbinafine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000201	0.000647	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.0002	0.000643	CcSEcCtD
Terbinafine—Skin disorder—Epirubicin—urinary bladder cancer	0.0002	0.000642	CcSEcCtD
Terbinafine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000198	0.000638	CcSEcCtD
Terbinafine—Myalgia—Doxorubicin—urinary bladder cancer	0.000198	0.000638	CcSEcCtD
Terbinafine—Chest pain—Doxorubicin—urinary bladder cancer	0.000198	0.000638	CcSEcCtD
Terbinafine—Anxiety—Doxorubicin—urinary bladder cancer	0.000198	0.000635	CcSEcCtD
Terbinafine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000197	0.000634	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000197	0.000633	CcSEcCtD
Terbinafine—Discomfort—Doxorubicin—urinary bladder cancer	0.000196	0.00063	CcSEcCtD
Terbinafine—Anorexia—Epirubicin—urinary bladder cancer	0.000196	0.00063	CcSEcCtD
Terbinafine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000194	0.000623	CcSEcCtD
Terbinafine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000193	0.000621	CcSEcCtD
Terbinafine—Confusional state—Doxorubicin—urinary bladder cancer	0.000192	0.000616	CcSEcCtD
Terbinafine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000191	0.000614	CcSEcCtD
Terbinafine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00019	0.000611	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00019	0.000609	CcSEcCtD
Terbinafine—Fatigue—Methotrexate—urinary bladder cancer	0.000189	0.000608	CcSEcCtD
Terbinafine—Infection—Doxorubicin—urinary bladder cancer	0.000189	0.000607	CcSEcCtD
Terbinafine—Pain—Methotrexate—urinary bladder cancer	0.000188	0.000604	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000187	0.000602	CcSEcCtD
Terbinafine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000186	0.000599	CcSEcCtD
Terbinafine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000186	0.000598	CcSEcCtD
Terbinafine—Skin disorder—Doxorubicin—urinary bladder cancer	0.000185	0.000594	CcSEcCtD
Terbinafine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000185	0.000593	CcSEcCtD
Terbinafine—Anorexia—Doxorubicin—urinary bladder cancer	0.000181	0.000583	CcSEcCtD
Terbinafine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000181	0.000582	CcSEcCtD
Terbinafine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000181	0.000581	CcSEcCtD
Terbinafine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00018	0.000577	CcSEcCtD
Terbinafine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000179	0.000574	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000177	0.00057	CcSEcCtD
Terbinafine—Fatigue—Epirubicin—urinary bladder cancer	0.000177	0.000569	CcSEcCtD
Terbinafine—Pain—Epirubicin—urinary bladder cancer	0.000176	0.000565	CcSEcCtD
Terbinafine—Urticaria—Methotrexate—urinary bladder cancer	0.000174	0.000561	CcSEcCtD
Terbinafine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000174	0.000558	CcSEcCtD
Terbinafine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000174	0.000558	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000173	0.000557	CcSEcCtD
Terbinafine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000171	0.000549	CcSEcCtD
Terbinafine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000169	0.000544	CcSEcCtD
Terbinafine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000168	0.00054	CcSEcCtD
Terbinafine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000167	0.000538	CcSEcCtD
Terbinafine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000165	0.000531	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000164	0.000528	CcSEcCtD
Terbinafine—Fatigue—Doxorubicin—urinary bladder cancer	0.000164	0.000527	CcSEcCtD
Terbinafine—Urticaria—Epirubicin—urinary bladder cancer	0.000163	0.000525	CcSEcCtD
Terbinafine—Pain—Doxorubicin—urinary bladder cancer	0.000163	0.000523	CcSEcCtD
Terbinafine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000162	0.000522	CcSEcCtD
Terbinafine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000162	0.000522	CcSEcCtD
Terbinafine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000162	0.00052	CcSEcCtD
Terbinafine—Asthenia—Methotrexate—urinary bladder cancer	0.000158	0.000506	CcSEcCtD
Terbinafine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000157	0.000504	CcSEcCtD
Terbinafine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000155	0.0005	CcSEcCtD
Terbinafine—Pruritus—Methotrexate—urinary bladder cancer	0.000155	0.000499	CcSEcCtD
Terbinafine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000151	0.000487	CcSEcCtD
Terbinafine—Urticaria—Doxorubicin—urinary bladder cancer	0.000151	0.000486	CcSEcCtD
Terbinafine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00015	0.000483	CcSEcCtD
Terbinafine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.00015	0.000483	CcSEcCtD
Terbinafine—Diarrhoea—Methotrexate—urinary bladder cancer	0.00015	0.000483	CcSEcCtD
Terbinafine—Asthenia—Epirubicin—urinary bladder cancer	0.000147	0.000474	CcSEcCtD
Terbinafine—Pruritus—Epirubicin—urinary bladder cancer	0.000145	0.000467	CcSEcCtD
Terbinafine—Dizziness—Methotrexate—urinary bladder cancer	0.000145	0.000467	CcSEcCtD
Terbinafine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000141	0.000452	CcSEcCtD
Terbinafine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00014	0.00045	CcSEcCtD
Terbinafine—Vomiting—Methotrexate—urinary bladder cancer	0.00014	0.000449	CcSEcCtD
Terbinafine—Rash—Methotrexate—urinary bladder cancer	0.000138	0.000445	CcSEcCtD
Terbinafine—Dermatitis—Methotrexate—urinary bladder cancer	0.000138	0.000445	CcSEcCtD
Terbinafine—Headache—Methotrexate—urinary bladder cancer	0.000138	0.000442	CcSEcCtD
Terbinafine—Asthenia—Doxorubicin—urinary bladder cancer	0.000136	0.000438	CcSEcCtD
Terbinafine—Dizziness—Epirubicin—urinary bladder cancer	0.000136	0.000437	CcSEcCtD
Terbinafine—Pruritus—Doxorubicin—urinary bladder cancer	0.000135	0.000432	CcSEcCtD
Terbinafine—Vomiting—Epirubicin—urinary bladder cancer	0.000131	0.00042	CcSEcCtD
Terbinafine—Nausea—Methotrexate—urinary bladder cancer	0.00013	0.000419	CcSEcCtD
Terbinafine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00013	0.000418	CcSEcCtD
Terbinafine—Rash—Epirubicin—urinary bladder cancer	0.00013	0.000416	CcSEcCtD
Terbinafine—Dermatitis—Epirubicin—urinary bladder cancer	0.000129	0.000416	CcSEcCtD
Terbinafine—Headache—Epirubicin—urinary bladder cancer	0.000129	0.000414	CcSEcCtD
Terbinafine—Dizziness—Doxorubicin—urinary bladder cancer	0.000126	0.000404	CcSEcCtD
Terbinafine—Nausea—Epirubicin—urinary bladder cancer	0.000122	0.000392	CcSEcCtD
Terbinafine—Vomiting—Doxorubicin—urinary bladder cancer	0.000121	0.000389	CcSEcCtD
Terbinafine—Rash—Doxorubicin—urinary bladder cancer	0.00012	0.000385	CcSEcCtD
Terbinafine—Dermatitis—Doxorubicin—urinary bladder cancer	0.00012	0.000385	CcSEcCtD
Terbinafine—Headache—Doxorubicin—urinary bladder cancer	0.000119	0.000383	CcSEcCtD
Terbinafine—Nausea—Doxorubicin—urinary bladder cancer	0.000113	0.000363	CcSEcCtD
Terbinafine—PTGS1—Metabolism—TYMP—urinary bladder cancer	7.27e-05	0.000353	CbGpPWpGaD
Terbinafine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	7.16e-05	0.000348	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	7.09e-05	0.000344	CbGpPWpGaD
Terbinafine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.06e-05	0.000343	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.98e-05	0.000339	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	6.91e-05	0.000336	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NAT1—urinary bladder cancer	6.91e-05	0.000336	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.8e-05	0.00033	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—RRM2—urinary bladder cancer	6.74e-05	0.000327	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	6.71e-05	0.000326	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	6.65e-05	0.000323	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—PTEN—urinary bladder cancer	6.62e-05	0.000321	CbGpPWpGaD
Terbinafine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	6.58e-05	0.00032	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—NAT2—urinary bladder cancer	6.57e-05	0.000319	CbGpPWpGaD
Terbinafine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.49e-05	0.000315	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.43e-05	0.000312	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	6.38e-05	0.00031	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	6.36e-05	0.000309	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	6.36e-05	0.000309	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—GSTP1—urinary bladder cancer	6.33e-05	0.000308	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	6.32e-05	0.000307	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—EP300—urinary bladder cancer	6.31e-05	0.000306	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NAT1—urinary bladder cancer	6.3e-05	0.000306	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	6.3e-05	0.000306	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—ENO2—urinary bladder cancer	6.24e-05	0.000303	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—HPGDS—urinary bladder cancer	6.24e-05	0.000303	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.2e-05	0.000301	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.2e-05	0.000301	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.13e-05	0.000298	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—GSTT1—urinary bladder cancer	6.05e-05	0.000294	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	6.02e-05	0.000293	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.96e-05	0.000289	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—TYMS—urinary bladder cancer	5.89e-05	0.000286	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	5.87e-05	0.000285	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—GSTM1—urinary bladder cancer	5.82e-05	0.000283	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—NCOR1—urinary bladder cancer	5.82e-05	0.000283	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	5.82e-05	0.000282	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	5.77e-05	0.00028	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	5.69e-05	0.000277	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	5.68e-05	0.000276	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—RRM2—urinary bladder cancer	5.67e-05	0.000275	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—GPX1—urinary bladder cancer	5.57e-05	0.000271	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—ERCC2—urinary bladder cancer	5.47e-05	0.000266	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	5.39e-05	0.000262	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NAT1—urinary bladder cancer	5.39e-05	0.000262	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	5.38e-05	0.000261	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.3e-05	0.000257	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—HPGDS—urinary bladder cancer	5.25e-05	0.000255	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—ENO2—urinary bladder cancer	5.25e-05	0.000255	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	5.24e-05	0.000254	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	5.24e-05	0.000254	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.22e-05	0.000254	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	5.19e-05	0.000252	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—MTHFR—urinary bladder cancer	5.14e-05	0.00025	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—GSTT1—urinary bladder cancer	5.1e-05	0.000247	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—NQO1—urinary bladder cancer	5.03e-05	0.000244	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.02e-05	0.000244	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	4.95e-05	0.00024	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	4.93e-05	0.000239	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	4.9e-05	0.000238	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.88e-05	0.000237	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	4.82e-05	0.000234	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	4.78e-05	0.000232	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.71e-05	0.000229	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—TYMP—urinary bladder cancer	4.69e-05	0.000228	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.51e-05	0.000219	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	4.44e-05	0.000215	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	4.39e-05	0.000213	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.26e-05	0.000207	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—NAT2—urinary bladder cancer	4.24e-05	0.000206	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—NQO1—urinary bladder cancer	4.23e-05	0.000206	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.2e-05	0.000204	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—GSTP1—urinary bladder cancer	4.2e-05	0.000204	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	4.19e-05	0.000203	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	4.19e-05	0.000203	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PPARG—urinary bladder cancer	4.17e-05	0.000203	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	4.16e-05	0.000202	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	4.16e-05	0.000202	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.11e-05	0.0002	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	4.08e-05	0.000198	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.06e-05	0.000197	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.02e-05	0.000195	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—CREBBP—urinary bladder cancer	4.01e-05	0.000195	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—TYMS—urinary bladder cancer	3.9e-05	0.000189	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—NCOR1—urinary bladder cancer	3.86e-05	0.000187	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—GSTM1—urinary bladder cancer	3.86e-05	0.000187	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	3.85e-05	0.000187	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.83e-05	0.000186	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—TYMP—urinary bladder cancer	3.82e-05	0.000185	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.8e-05	0.000185	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	3.79e-05	0.000184	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—GPX1—urinary bladder cancer	3.69e-05	0.000179	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.67e-05	0.000178	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—RRM2—urinary bladder cancer	3.66e-05	0.000178	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—ERCC2—urinary bladder cancer	3.63e-05	0.000176	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.58e-05	0.000174	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—GSTP1—urinary bladder cancer	3.53e-05	0.000171	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	3.48e-05	0.000169	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NAT2—urinary bladder cancer	3.45e-05	0.000168	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.42e-05	0.000166	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.42e-05	0.000166	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—MTHFR—urinary bladder cancer	3.41e-05	0.000165	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	3.39e-05	0.000165	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ENO2—urinary bladder cancer	3.39e-05	0.000165	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.37e-05	0.000164	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	3.29e-05	0.00016	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—TYMS—urinary bladder cancer	3.28e-05	0.000159	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PTGS2—urinary bladder cancer	3.28e-05	0.000159	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.27e-05	0.000159	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	3.27e-05	0.000159	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	3.26e-05	0.000159	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—NCOR1—urinary bladder cancer	3.25e-05	0.000158	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—GSTM1—urinary bladder cancer	3.25e-05	0.000158	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.24e-05	0.000157	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.23e-05	0.000157	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.15e-05	0.000153	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.14e-05	0.000152	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—GPX1—urinary bladder cancer	3.11e-05	0.000151	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—ERCC2—urinary bladder cancer	3.05e-05	0.000148	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	3.03e-05	0.000147	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	3.03e-05	0.000147	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.01e-05	0.000146	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	3.01e-05	0.000146	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—RRM2—urinary bladder cancer	2.98e-05	0.000145	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	2.95e-05	0.000143	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	2.94e-05	0.000143	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.89e-05	0.00014	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—MTHFR—urinary bladder cancer	2.87e-05	0.000139	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PTEN—urinary bladder cancer	2.86e-05	0.000139	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	2.79e-05	0.000135	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	2.79e-05	0.000135	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PPARG—urinary bladder cancer	2.76e-05	0.000134	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2.76e-05	0.000134	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2.76e-05	0.000134	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.75e-05	0.000133	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—NQO1—urinary bladder cancer	2.74e-05	0.000133	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—EP300—urinary bladder cancer	2.73e-05	0.000133	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	2.7e-05	0.000131	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	2.68e-05	0.00013	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—CREBBP—urinary bladder cancer	2.65e-05	0.000129	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.65e-05	0.000129	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.64e-05	0.000128	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.55e-05	0.000124	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.52e-05	0.000122	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	2.44e-05	0.000119	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.37e-05	0.000115	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	2.36e-05	0.000115	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	2.36e-05	0.000115	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.35e-05	0.000114	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PPARG—urinary bladder cancer	2.33e-05	0.000113	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.31e-05	0.000112	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	2.29e-05	0.000111	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	2.28e-05	0.000111	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.28e-05	0.000111	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.25e-05	0.000109	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	2.25e-05	0.000109	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CREBBP—urinary bladder cancer	2.23e-05	0.000108	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	2.23e-05	0.000108	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.21e-05	0.000107	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PTGS2—urinary bladder cancer	2.17e-05	0.000106	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.16e-05	0.000105	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—TYMS—urinary bladder cancer	2.12e-05	0.000103	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	2.1e-05	0.000102	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	2.1e-05	0.000102	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.07e-05	0.0001	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	2.04e-05	9.89e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GPX1—urinary bladder cancer	2.01e-05	9.75e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	1.97e-05	9.57e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.97e-05	9.57e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.97e-05	9.55e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.9e-05	9.24e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PTEN—urinary bladder cancer	1.9e-05	9.21e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.89e-05	9.19e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.88e-05	9.15e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.87e-05	9.09e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.87e-05	9.09e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.87e-05	9.09e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.86e-05	9.02e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.85e-05	9e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.85e-05	8.96e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PTGS2—urinary bladder cancer	1.83e-05	8.88e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.82e-05	8.84e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.82e-05	8.84e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—EP300—urinary bladder cancer	1.81e-05	8.78e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.8e-05	8.72e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.79e-05	8.7e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.77e-05	8.58e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.76e-05	8.54e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.74e-05	8.45e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.73e-05	8.38e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.72e-05	8.36e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.72e-05	8.36e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.71e-05	8.29e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.71e-05	8.29e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.65e-05	8.03e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.65e-05	8e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.63e-05	7.93e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.62e-05	7.86e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.61e-05	7.82e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.6e-05	7.79e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PTEN—urinary bladder cancer	1.6e-05	7.75e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.59e-05	7.7e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.54e-05	7.45e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—EP300—urinary bladder cancer	1.52e-05	7.39e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.52e-05	7.39e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.51e-05	7.32e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.5e-05	7.3e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.48e-05	7.16e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.47e-05	7.13e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.46e-05	7.08e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.46e-05	7.08e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.44e-05	7.01e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.4e-05	6.78e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.37e-05	6.66e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.34e-05	6.51e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.29e-05	6.26e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.29e-05	6.26e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.23e-05	5.99e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.22e-05	5.95e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.22e-05	5.94e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.18e-05	5.75e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	1.18e-05	5.74e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.17e-05	5.7e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.14e-05	5.53e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.13e-05	5.46e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.13e-05	5.46e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.08e-05	5.23e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.06e-05	5.14e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.05e-05	5.12e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.04e-05	5.07e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.03e-05	5e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1e-05	4.87e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	9.94e-06	4.83e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—EP300—urinary bladder cancer	9.83e-06	4.77e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	9.7e-06	4.71e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	9.62e-06	4.67e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	9.2e-06	4.47e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—EP300—urinary bladder cancer	8.77e-06	4.26e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	8.46e-06	4.11e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	8.39e-06	4.07e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	8.22e-06	3.99e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—EP300—urinary bladder cancer	8.07e-06	3.92e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	8.06e-06	3.92e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—EP300—urinary bladder cancer	8e-06	3.88e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	7.75e-06	3.76e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	7.17e-06	3.48e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—EP300—urinary bladder cancer	6.84e-06	3.32e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	6.34e-06	3.08e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	5.53e-06	2.69e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—EP300—urinary bladder cancer	5.28e-06	2.56e-05	CbGpPWpGaD
